DELIVER at the AHA 2023

The DELIVER team was proud to present at AHA 2023 in Philadelphia, Pennsylvania. The following analyses were presented:

• Efficacy and Safety of Dapagliflozin in Patients With Heart Failure and Previous Myocardial Infarction presented by Alexander Peikert

• Characteristics, Outcomes and Treatment Response With Dapagliflozin Across the Range of Ejection Fraction in People With HF and a History of CABG Surgery: A Pooled Analysis From DAPA-HF and DELIVER presented by Subodh Verma

• Initial Decline in Estimated Glomerular Filtration Rate After Initiation of Dapagliflozin in Patients With Heart Failure and Mildly Reduced or Preserved Reduced Ejection Fraction presented by Finnian Mc Causland